Please Wait
Applying Filters...
menu
    • menu
    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Quemliclustat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arcus Biosciences’ Quemliclustat Receives Orphan Drug Designation
    Arcus Biosciences’ Quemliclustat Receives Orphan Drug Designation

    10 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250710694880/en/Arcus-Biosciences-Quemliclustat-Receives-Orphan-Drug-Designation-for-Pancreatic-Cancer

    BUSINESSWIRE
    10 Jul 2025
    Share Share
    Data from a Phase 1b Study of Quemliclustat-Based Regimens Showed Promising Overall Survival in Treatment-Naïve Metastatic Pancreatic Cancer
    Data from a Phase 1b Study of Quemliclustat-Based Regimens Showed Promising Overall Survival in Treatment-Naïve Metastatic Pancreatic Cancer

    16 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240116940666/en

    BUSINESSWIRE
    16 Jan 2024
    Share Share
    Arcus Biosciences Reports Second Quarter 2022 Financial Results
    Arcus Biosciences Reports Second Quarter 2022 Financial Results

    03 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220803005357/en

    BUSINESSWIRE
    03 Aug 2022
    Share Share